India, Sept. 24 -- This company is a pharmaceutical company whose activities include the production and development of fermentation derived APIs and dosage forms. This company has an involvement in the field of immunosuppressants, anti-infectives, and other pharmaceuticals. Its products cater to domestic as well as international markets.

The shares of Concord Biotech are currently trading at Rs. 1,506.40, down by 3.49%. The company has a market capitalization of Rs. 15,759.38 crore. The stock's 52week high is Rs. 1,667.60 and its 52 week low is Rs. 987.00. In the past 6 months the stock has delivered a return of 45.01%.

What's The News Proposal for bonus share has been passed by the board of directors of Concord Biotech. The ratio of t...